Sertraline Pharmacokinetics and Dynamics in Adolescents
- 1 September 2002
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 41 (9), 1037-1044
- https://doi.org/10.1097/00004583-200209000-00003
Abstract
No abstract availableKeywords
Funding Information
- NIMH (grants MH-18591 and MH-55123 (PI: Dr. Brent), MH-70008 (PI: Dr. Birmaher), MH-30915 (Core PI: Dr. Perel), and MH-01878 (PI: Dr. Axelson))
This publication has 23 references indexed in Scilit:
- Paroxetine Pharmacokinetics in Depressed Children and AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- Multicenter Open‐Label Sertraline Study in Adolescent Outpatients With Major DepressionJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- Sertraline Treatment of Children and Adolescents With Obsessive‐Compulsive Disorder or Depression: Pharmacokinetics, Tolerability, and EfficacyJournal of the American Academy of Child & Adolescent Psychiatry, 1998
- Pharmacokinetics of Sertraline and its N-Demethyl Metabolite in Elderly and Young Male and Female VolunteersClinical Pharmacokinetics, 1997
- Clinically Relevant Pharmacology of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1997
- Sertraline 50 mg daily: the optimal dose in the treatment of depressionInternational Clinical Psychopharmacology, 1995
- High-Performance Liquid Chromatography Determination of Dextromethorphan and Dextrorphan for Oxidation Phenotyping by Fluorescence and Ultraviolet DetectionTherapeutic Drug Monitoring, 1993
- Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin TransporterJournal of Neurochemistry, 1993
- Clinical Implications of the Pharmacology of SertralineInternational Clinical Psychopharmacology, 1991
- Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depressionPsychopharmacology, 1979